Complication | Evidence | PMID |
Atherosclerosis | 1. Studies in cells and animal models support that leptin has a pro-atherogenic potential and exerts pro-hypertrophic effects on the heart. | 26126055 |
Neuropathy | 1. The leptin-deficient ob/ob mouse is a new animal model that develops both large motor and sensory fiber and small sensory fiber peripheral diabetic neuropathy (PDN). | 17130477 |
Nephropathy | 1. The ZDSD rat is a new obese-diabetic rat model that expresses type 2 diabetes in the presence of an intact leptin pathway,results position the ZDSD rat as a relevant model of diabetic nephropathy that can be treated with clinically effective compounds. | 28979697 |
Cardiovascular | 1. CONCLUSIONS: These results indicate that canagliflozin may improve adipose tissue function and induce changes in serum leptin, adiponectin, and IL-6 that favorably impact insulin sensitivity and cardiovascular disease risk. | 28967613 |
Dyslipidemia | 1. Leptin is associated with general and abdominal obesity, dyslipidemia, and insulin resistance in Kyrgyz patients. | 28967613 |
Insulin resistance and inflammation | 1. First, next to leptin, the circulating mediators chemerin, tissue inhibitor of metalloproteinase 1, EGF and TNF receptor 2 were identified as novel inflammatory mediators that are increased in childhood obesity. | 24981337 |